Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 150.0 % Shares of NAVB opened at $0.00 on Tuesday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 150.0 % Shares of NAVB opened at $0.00 on Tuesday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week […]
